PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic collaboration to ...

BOSTON and CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system, ...

Boston-based PathAI is adding a suite of laboratory testing services to its portfolio of artificial intelligence-powered pathology tools through its acquisition of Poplar Healthcare Management. Poplar ...

PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche. The strategic partnership will allow PathAI to develop and distribute its AI ...

As part of efforts to accelerate the use of artificial intelligence to improve quality, speed and efficiency in diagnosing cancer and other diseases, Quest Diagnostics will acquire key assets of ...

The pathway between testing for cancer and other diseases and reaching a diagnosis just got a lot shorter. With its recent acquisition of Poplar Healthcare Management, the management service ...

BOSTON, Jan. 29, 2019 /PRNewswire-PRWeb/ -- PathAI announced today that it has received certification of its quality management system for compliance with ISO 13485 and MDSAP for US regulations, an ...

Quest Diagnostics DGX recently announced a multi-faceted collaboration with PathAI to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in ...

Quest Diagnostics completed its previously announced acquisition of key assets from Boston biotech PathAI Diagnostics. In a June 11 press release, the Secaucus-based testing provider announced the ...

BOSTON & CLEVELAND--(BUSINESS WIRE)--PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Cleveland Clinic today announced a five-year strategic collaboration ...